Is a complete BCBA/NTRA research report available?

No complete published report is available for bcba/NTRA (BCBA/NTRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NTRA (BCBA/NTRA)

Buenos Aires Stock Exchange: BCBA/NTRA · ARS

ARS 13,970

+670.30 (+5.0%)· Recorded snapshot

Market cap	94.1T
Revenue (ttm)	4T
Net income (ttm)	-285B
EPS (ttm)	-ARS 41.5
Volume	5,802

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4T
Net income (ttm): -285B
EPS (ttm): -ARS 41.5
Market cap: 94.1T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-06
Employees	6,140
Employees change	1,706
Employees growth	38.48%
Enterprise value	ARS 92.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-09-05
Fiscal year end	December
Founded	2003
Industry	Diagnostics & Research
Is primary listing	No
ISIN number	AR0776810878
Last refreshed	2026-10-29
Market cap	ARS 94.1T
Next earnings date	2026-11-06
Price	ARS 13,970.00
Price currency	ARS
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	bcba/NTRA
Website	https://www.natera.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-06

Employees

6,140

Employees change

1,706

Employees growth

38.48%

Enterprise value

ARS 92.7T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-09-05

Fiscal year end

December

Founded

2003

Industry

Diagnostics & Research

Is primary listing

ISIN number

AR0776810878

Last refreshed

2026-10-29

Market cap

ARS 94.1T

Next earnings date

2026-11-06

Price

ARS 13,970.00

Price currency

ARS

Sector

Healthcare

SIC code

8071

Stock price date

2026-10-28

Symbol

bcba/NTRA

Website

https://www.natera.com

Metric	Value
Earnings yield	-0.3%
EV/FCF	743.5x
EV/Sales	22.28x
FCF / EV yield	0.13%
FCF yield	0.13%
P/B ratio	34.85x
P/FCF ratio	754.02x
P/OCF ratio	278.16x
P/S ratio	23.45x
Price / tangible book value	48.09x

Metric

Value

Earnings yield

-0.3%

EV/FCF

743.5x

EV/Sales

22.28x

FCF / EV yield

0.13%

FCF yield

0.13%

P/B ratio

34.85x

P/FCF ratio

754.02x

P/OCF ratio

278.16x

P/S ratio

23.45x

Price / tangible book value

48.09x

Metric	Value
EBIT margin	-10.54%
EBITDA margin	-8.29%
FCF margin	2.99%
Gross margin	65.23%
Operating margin	-10.54%
Pretax margin	-9.33%
Profit margin	-7.11%
Profit per employee	ARS -46.4M
Revenue per employee	ARS 653.4M
ROA	-8.08%
ROA (5Y)	-18.17%
ROCE	-13.55%
ROE	-12.54%
ROE (5Y)	-51.25%
ROIC	-10.18%
SBC / revenue	14.09%
Tax / revenue	-2.23%

Metric

Value

EBIT margin

-10.54%

EBITDA margin

-8.29%

FCF margin

2.99%

Gross margin

65.23%

Operating margin

-10.54%

Pretax margin

-9.33%

Profit margin

-7.11%

Profit per employee

ARS -46.4M

Revenue per employee

ARS 653.4M

ROA

-8.08%

ROA (5Y)

-18.17%

ROCE

-13.55%

ROE

-12.54%

ROE (5Y)

-51.25%

ROIC

-10.18%

SBC / revenue

14.09%

Tax / revenue

-2.23%

Metric	Value
EPS growth quarters	1
EPS growth years	3
FCF growth	-19.47%
Gross profit growth	43.01%
Gross profit growth (Q)	39.98%
Gross profit growth 3Y	64.6%
Gross profit growth 5Y	47.82%
Net income growth quarters	1
Net income growth years	0
OCF growth	22.25%
OCF growth (Q)	45.83%
OCF growth (QoQ)	36.4%
Revenue growth	37.82%
Revenue growth (Q)	37.72%
Revenue growth (QoQ)	8.05%
Revenue growth 10Y	29.03%
Revenue growth 3Y	42.73%
Revenue growth 5Y	39.92%
Revenue growth quarters	37
Revenue growth years	8

Metric

Value

EPS growth quarters

EPS growth years

FCF growth

-19.47%

Gross profit growth

43.01%

Gross profit growth (Q)

39.98%

Gross profit growth 3Y

64.6%

Gross profit growth 5Y

47.82%

Net income growth quarters

Net income growth years

OCF growth

22.25%

OCF growth (Q)

45.83%

OCF growth (QoQ)

36.4%

Revenue growth

37.82%

Revenue growth (Q)

37.72%

Revenue growth (QoQ)

8.05%

Revenue growth 10Y

29.03%

Revenue growth 3Y

42.73%

Revenue growth 5Y

39.92%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -213.4B
Depreciation and amortization	ARS 93.7B
EBIT	ARS -422.6B
EBITDA	ARS -332.5B
EPS	ARS -41.50
Financing cash flow	ARS 74.5B
Free cash flow	ARS 124.7B
Free cash flow minus SBC	ARS -440.3B
Gross profit	ARS 2.6T
Income taxes	ARS -89.4B
Investing cash flow	ARS -277.1B
Net cash flow	ARS 135.5B
Net income	ARS -285B
Operating cash flow minus SBC	ARS -226.9B
Operating income	ARS -422.6B
Revenue	ARS 4T
Stock-based compensation	ARS 565.1B

Metric

Value

Capital expenditures

ARS -213.4B

Depreciation and amortization

ARS 93.7B

EBIT

ARS -422.6B

EBITDA

ARS -332.5B

EPS

ARS -41.50

Financing cash flow

ARS 74.5B

Free cash flow

ARS 124.7B

Free cash flow minus SBC

ARS -440.3B

Gross profit

ARS 2.6T

Income taxes

ARS -89.4B

Investing cash flow

ARS -277.1B

Net cash flow

ARS 135.5B

Net income

ARS -285B

Operating cash flow minus SBC

ARS -226.9B

Operating income

ARS -422.6B

Revenue

ARS 4T

Stock-based compensation

ARS 565.1B

Metric	Value
Altman Z-Score	19.48
Book value per share	ARS 18,790.57
Debt / equity	0.13
Debt / FCF	2.83
Goodwill	ARS 217.5B
Interest coverage	-74.72
Long-term assets	ARS 1.4T
Long-term liabilities	ARS 385.6B
Net cash (debt)	ARS 1.3T
Net cash / market cap	1.34%
Net cash growth	4.04%
Net debt / equity	-0.47
Net debt / FCF	-10.13
Piotroski F-Score	4
Property, plant and equipment	ARS 689.6B
Shareholders' equity	ARS 2.7T
Tangible book value	ARS 2T
Tangible book value per share	ARS 13,619.12
Total assets	ARS 3.9T
Total cash	ARS 1.6T
Total debt	ARS 353.3B
Total liabilities	ARS 1.2T

Metric

Value

Altman Z-Score

19.48

Book value per share

ARS 18,790.57

Debt / equity

0.13

Debt / FCF

2.83

Goodwill

ARS 217.5B

Interest coverage

-74.72

Long-term assets

ARS 1.4T

Long-term liabilities

ARS 385.6B

Net cash (debt)

ARS 1.3T

Net cash / market cap

1.34%

Net cash growth

4.04%

Net debt / equity

-0.47

Net debt / FCF

-10.13

Piotroski F-Score

Property, plant and equipment

ARS 689.6B

Shareholders' equity

ARS 2.7T

Tangible book value

ARS 2T

Tangible book value per share

ARS 13,619.12

Total assets

ARS 3.9T

Total cash

ARS 1.6T

Total debt

ARS 353.3B

Total liabilities

ARS 1.2T

Metric	Value
Asset turnover	1.23
Current assets	ARS 2.6T
Current liabilities	ARS 852.9B
Current ratio	3
Inventory turnover	13.98
Net working capital	ARS 162.5B
Quick ratio	2.74
Working capital	ARS 1.6T
Working capital turnover	3,726.38

Metric

Value

Asset turnover

1.23

Current assets

ARS 2.6T

Current liabilities

ARS 852.9B

Current ratio

Inventory turnover

13.98

Net working capital

ARS 162.5B

Quick ratio

2.74

Working capital

ARS 1.6T

Working capital turnover

3,726.38

Metric	Value
Buyback yield / dilution	-6.45%
Shareholder yield	-6.45%

Metric

Value

Buyback yield / dilution

-6.45%

Shareholder yield

-6.45%

Metric	Value
1D price change	5.04%
1M price change	6.97%
1M total return	6.97%
1W price change	4.96%
1W total return	4.96%
20-day SMA	ARS 12,917.50
52-week high	ARS 14,060.00
52-week high date	2026-10-28
52-week low	ARS 9,900.00
52-week low date	2026-09-08
All-time high	ARS 14,060.00
All-time high date	2026-10-28
All-time low	ARS 9,900.00
All-time low date	2026-09-08
Average true range (ATR)	ARS 468.55
Average volume	3.1K
Change from 52-week high	0%
Change from 52-week low	41.11%
Change from all-time high	-0.64%
Change from all-time low	41.11%
Change from open	1.23%
Day's gap	3.76%
Dollar volume	ARS 81.1M
High price	ARS 14,060.00
Low price	ARS 13,800.00
Monthly RSI	0
Open price	ARS 13,800.00
Position in 52-week range	65.38%
Previous close	ARS 13,300.00
Price vs 20-day SMA	8.15%
Relative volume	2.35
RSI	69.65
Sharpe ratio	5.24
Sortino ratio	9.44
Volume	5.8K
Weekly RSI	0

Metric

Value

1D price change

5.04%

1M price change

6.97%

1M total return

6.97%

1W price change

4.96%

1W total return

4.96%

20-day SMA

ARS 12,917.50

52-week high

ARS 14,060.00

52-week high date

2026-10-28

52-week low

ARS 9,900.00

52-week low date

2026-09-08

All-time high

ARS 14,060.00

All-time high date

2026-10-28

All-time low

ARS 9,900.00

All-time low date

2026-09-08

Average true range (ATR)

ARS 468.55

Average volume

3.1K

Change from 52-week high

Change from 52-week low

41.11%

Change from all-time high

-0.64%

Change from all-time low

41.11%

Change from open

1.23%

Day's gap

3.76%

Dollar volume

ARS 81.1M

High price

ARS 14,060.00

Low price

ARS 13,800.00

Monthly RSI

Open price

ARS 13,800.00

Position in 52-week range

65.38%

Previous close

ARS 13,300.00

Price vs 20-day SMA

8.15%

Relative volume

2.35

RSI

69.65

Sharpe ratio

5.24

Sortino ratio

9.44

Volume

5.8K

Weekly RSI

Metric	Value
Float	140.1M
Shares change (QoQ)	1.26%
Shares change (YoY)	6.45%
Shares held by insiders	2.74%
Shares held by institutions	96.89%
Short ratio	3.9 days

Metric

Value

Float

140.1M

Shares change (QoQ)

1.26%

Shares change (YoY)

6.45%

Shares held by insiders

2.74%

Shares held by institutions

96.89%

Short ratio

3.9 days

BCBA/NTRA (BCBA/NTRA)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NTRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NTRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NTRA

Frequently asked questions